Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01724502 · ClinicalTrials.gov registry record · NA

Mitochondrial Dysfunction in Diabetes

A NA study of Diabetes and Obese, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT01724502 is a NA study of Diabetes and Obese that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01724502, a NA study of Diabetes and Obese, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether insulin resistance is accompanied by "exercise resistance". Investigators will use mass spectrometry and proteomics analysis to test the hypothesis is that a bout of exercise that increases mitochondrial protein abundance in lean, healthy individuals is less effective in insulin resistant patients.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise and muscle biopsies

Study Locations (1)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2012-09
Est. Completion 2014-03
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01724502

The ClinicalTrials.gov registry entry for NCT01724502 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Exercise and muscle biopsies is the first listed.

NCT01724502 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT01724502 about?

NCT01724502 is a clinical study titled "Mitochondrial Dysfunction in Diabetes". The purpose of this study is to determine whether insulin resistance is accompanied by "exercise resistance". Investigators will use mass spectrometry and proteomics analysis to test the hypothesis is that a bout of exercise that increases mitochondrial protein abundance in lean, healthy individuals...

What is the current status of trial NCT01724502?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2012-09. Estimated completion is 2014-03.

What conditions does trial NCT01724502 study?

This clinical trial studies the following conditions: Diabetes, Obese.

What interventions are being tested in trial NCT01724502?

The interventions under investigation include: Exercise and muscle biopsies (BEHAVIORAL).

Who is sponsoring clinical trial NCT01724502?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01724502 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.